LSI USA '23 filling fast. Register Now


Optimization of T cell receptors (TCRs) for use in adoptive T cell therapy - to target and destroy cancerous/infected cells

Start Trial Get Full Profile

There’s no risk. Start your trial today to see profiles of Adaptimmune plus 5403 other startups.

Start Free 7 Day Trial Now

Learn More About Adaptimmune

Technology/product details

Competing Startups


Our Clients